LogicBio Therapeutics, Inc. Debt to Equity Ratio 2018-2022 | LOGC
Current and historical debt to equity ratio values for LogicBio Therapeutics, Inc. (LOGC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. LogicBio Therapeutics, Inc. debt/equity for the three months ending September 30, 2022 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-09-30 |
$0.02B |
$0.02B |
1.45 |
2022-06-30 |
$0.03B |
$0.02B |
1.27 |
2022-03-31 |
$0.03B |
$0.03B |
1.08 |
2021-12-31 |
$0.03B |
$0.03B |
1.04 |
2021-09-30 |
$0.03B |
$0.04B |
0.76 |
2021-06-30 |
$0.03B |
$0.05B |
0.74 |
2021-03-31 |
$0.02B |
$0.05B |
0.36 |
2020-12-31 |
$0.02B |
$0.06B |
0.31 |
2020-09-30 |
$0.02B |
$0.02B |
0.88 |
2020-06-30 |
$0.02B |
$0.03B |
0.68 |
2020-03-31 |
$0.02B |
$0.03B |
0.45 |
2019-12-31 |
$0.01B |
$0.04B |
0.32 |
2019-09-30 |
$0.01B |
$0.05B |
0.26 |
2019-06-30 |
$0.01B |
$0.06B |
0.07 |
2019-03-31 |
$0.00B |
$0.07B |
0.05 |
2018-12-31 |
$0.00B |
$0.08B |
0.03 |
2018-09-30 |
$0.04B |
$-0.02B |
-1.91 |
2018-06-30 |
$0.00B |
|
0.00 |
2018-03-31 |
$0.00B |
|
0.00 |
2017-09-30 |
$0.00B |
|
0.00 |